chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cough; This spontaneous case was reported by a patient and describes the occurrence of COUGH (cough) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included Cold.    On 19-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 20-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medication was reported.  No treatment information was reported.   Reporter did not allow further contact
Body chills, fatigue, sore muscles, slight fever, headache, and night sweats.
chest pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administration date 23Jul2021 (Lot number: EW0176) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CHEST PAIN (non-serious) with onset 24Jul2021, outcome "recovered" (25Jul2021), described as "chest pain".  Additional information: Caller says that she is calling because she had the 1st dose of the Pfizer COVID vaccine on 23Jul2021 and the day after and the next day she had sharp chest pains. She talked to her doctor about being revaccinated and the doctor wasn't sure if the caller could be revaccinated.   Follow-up attempts are completed. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 17-JUN-2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at his primary care physician, for routine health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. In approximately 2016 [reported as "shortly after" receiving ZOSTAVAX], the patient began to experience trouble in raising his right foot, and pain traveling up his right leg emanating from his right foot. The patient presented to a neurologist and was diagnosed with multifocal motor neuropathy. Thereafter (exact date not provided), the patient presented to a pathologist and was diagnosed as suffering from polyradiculoneuropathy and chronic inflammatory demyelinating polyneuritis. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, multifocal motor neuropathy and polyradiculoneuropathy/chronic inflammatory demyelinating polyneuritis were determined to be medically significant. Additional information has been requested.
Sore throat, difficulty breathing, increase heart rate, severe fatigue, horrible achiness mostly in extremities, prickly sensation into legs causing legs/feet to feel very hot, difficulty walking related to weakness. Course of symptoms lasted all night by 9:30 am after sleeping the symptoms were gone. Also upon awakening my eyelids were stuck together with yellow matter. No treatment was necessary.
Pt. passed out while checking out. When she passed out she hit her chin on the counter. Pt. had to go to the ER for stitches.
Start breaking out black and blue bruises all over my leg/come back the black blue bruises all over my hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Jul2021 (Lot number: EW0198) as dose 1,single and administered in arm left, administration date 13Aug2021 (Lot number: FC3181) as dose 2,single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (ongoing); "Acid Reflux" (unspecified if ongoing); "Migraine" (unspecified if ongoing). Concomitant medication(s) included: ERGOCALCIFEROL; CETIRIZINE; CHANTIX; CYCLOBENZAPRINE; MONTELUKAST; ATORVASTATIN taken for blood cholesterol; OMEPRAZOLE taken for gastrooesophageal reflux disease; AMLODIPINE taken for blood pressure measurement; CALCIUM; GABAPENTIN; ASPIRIN [ACETYLSALICYLIC ACID]; SUMATRIPTAN taken for migraine. The following information was reported: CONTUSION (non-serious) with onset 21Jul2021, outcome "not recovered", described as "Start breaking out black and blue bruises all over my leg/come back the black blue bruises all over my hand". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of contusion. No follow-up attempts are possible. No further information is expected.
The vaccination was received on Sunday, March 19, 2023.  On Tuesday March 21 I started feeling that a flu was coming on.  I had and continue to have a sore throat, runny nose with white sometimes yellow snot, a headache and muscle weakness.  These symptoms still are present today, perhaps worse than prior days. I am not experiencing any fever.
This is a spontaneous report from a contactable physician via a sales representative. A 20-year-old female patient of an unspecified ethnicity received the second dose of TRUMENBA, (lot number: S26985) intramuscular on 19Sep2017 at single dose in the deltoid for immunization. The patient's medical history was not reported. Concomitant medication included influenza vaccine taken for immunization. The patient previously took the first dose of TRUMENBA on an unspecified date. On 19Sep2017 the same night after receiving the vaccine, the patient experienced body aches, fever with temperature of 103 and chills. The outcome of the events was unknown.
Per patient parent, within two hours of receiving the MMRV vaccine, the patient began projectile vomiting, complained of pain, dizziness, and was noticeably tired. Within five hours of receiving MMRV the patient vomited a total of six times, developed a fever, and experienced soreness, redness and a raised mark at the injection site.  Per parent, pt had not received combo vaccine prior to this, only MMR and Varicella separately.
This spontaneous report as received from a nurse practitioner to unspecified number of patients of unknown age and gender. On an unknown date those patients were vaccinated with GARDASIL (dose, units, route of administration, anatomical location, lot number were not reported). The reporter stated that many patients had received the GARDASIL series off schedule. Information for those many patients were unknown. This is one of several reports from the same reporter. Additional information is not expected because the reported did not wish for follow up.
Other complications following immunization, not elsewhere classified, initial encounter on 2022-11-08.
SYNCOPE. PT STATED THEY WERE GOING TO PASS OUT, BUT NEVER DID. SHE LATER REPORTED THAT MY VOICE GOT SOFTER AND HAD TUNNEL VISION. DURING THE EVENT SHE STOPPED COMMUNICATING AND HAD A SLIGHT CONVULSION THAT LASTED ABOUT 20 SECONDS.  PT THEN FELT HOT, CLAMMY, AND "NOT GOOD".  PT FELT THIS WAY FOR ABOUT 5 MINUTES AND THEN FELT FINE.
Tonic-clonic generalized seizure duration 1 minute around 6-7 hours after 2 month immunizations. Report episode 2 days later, identical to first, No previous history of seizure or other abnormality, Positive family history of seizure
It has been 66 days since 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.
I suffered from a sudden onset of brain fog that occurred >30 minutes after my vaccine was given and was followed by feelings of mild anxiety. The morning after my vaccine I suffered from multiple repetitive anxiety attacks that lasted around an hour and resolved by noon.  I was using Tylenol 650 mg every 4-6 hours the day following my vaccine and Motrin 200 mg every 6 hours the afternoon and evening of my vaccine.  I did have the typical vaccine reactions as well post my second dose, but not following my first dose, and those symptoms lasted about 72 hours and varied in intensity.  I did have a rash on my left arm that came up after my second vaccine and lasted 5/7 days.
1st dose 12/30/2020 R arm tenderness 1/2 day 2nd dose 02/08/2021 9am L arm pain - all day  (Note: had 1st type shingles vaccine when 1st avail.)  Unable to use stairs/drive for 2 wks. O.T.C. Draminime helped. I took it for 3-4 days I reported my vertigo to a triage nurse from the clinic I go to. She found a reference to that as a possible symptom.  A family member told me she had been dx. with "atypical migraine: with these sx. - and was prescribed meclazine.  Hope this helps.  With all my allergies I rarely eat out - as you can guess. I believe this will become more common as globe hopping continues. Im 84 1/2. Ive shrunk to 5'2" and now weigh 144.2#. When I retired I was at 240#! I eat a very low carb diet, 2 meals/day and have gradually gotten to a good wt. I try to have all my carbs about 8am, and have my 2nd meal at about 3 ("Linner") w/o carbs. Thus I have no food cravings until the next day. Although I don't have ETOH probs. I rarely drink. (1 glass of wine in 2 yrs!) I raised 8 children while working in Mental Health 1969-2001. The kids were mine (3), his (3) and ours 2 grandkids we adopted upon my daughters death.  I still volunteer informally to friends. My concern is various types of involuntary care for dependent adults. A real problem. Thanks for the chance to provide input.
Arm is still very sore a week later; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (Patient's brother had shingles years ago). Previously administered products included Shingles vaccine with an associated reaction of limb discomfort (1st dose received on unknown date  For the tolerance of the 1st dose, refer linked case US2022AMR131245).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR131245   Additional Information: GSK Receipt Date: 10-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received second dose of Shingrix. The reporter stated that after received Shingrix vaccine the patient experienced arm sore and it was still very sore as a week later. The reporter stated patient covered not to get as his brother years ago had Shingles and it was extremely bad and painful. Follow-up would not possible as no contact details were available. Additional supportive information: For the tolerance of the 1st dose, refer linked case US2022AMR131245, reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR131245:Same reporter.
1-25-21 Noticed in the evening a red blotch just below the injection site a little bigger then a quarter. 1-26-21 Red blotch begins to look like a proper rash. Another red blotch forms just under and to the right of the first spot. 1-27-21 Both red blotches now look like a proper rash.
24 hours after receiving the vaccine I had muscle aches, body aches, and a headache that lasted for a day. When I caught covid it started with a severe headache. The next day I had congestion and diarrhea. I had body aches, a fever, fatigue and lost of appetite. That lasted for about 5 days then I was able to go to work after that. I took OTC Aspirin, Ibuprofen, Tylenol, and Zofran.  On and off I still get congestion that comes and goes.
pt was inadvertently given the Pfizer Movovalent as a booster dose she should have been given the bivalent , there was no adverse reaction pt will need to recieve the bivalent booster in 2 months
This spontaneous report has been received from a physician and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 06-SEP-2017, the patient was vaccinated with the first dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported) and on 07-SEP-2017, the patient was vaccinated with the second dose of GARDASIL 9 lot # M044717, expiration date 19-JUL-2019 (dose and route of administration were not reported). No adverse effects were reported. No product quality complaint has been filled.
myocarditis; This literature-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (myocarditis) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE:     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced MYOCARDITIS (myocarditis) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (myocarditis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Troponin: high (High) significantly elevated.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MYOCARDITIS (myocarditis) to be possibly related.    No concomitant medication was reported. Patient received supportive care. Patient presented with acute onset of marked chest pain within 4 days after receipt of an mRNA COVID-19 vaccine. Infectious, ischemic, or autoimmune etiologies was not identified for myocarditis. Patient was physically fit and lacking any known history of cardiac disease, significant cardiac risk factors, or exposure to cardiotoxic agents. No structural abnormalities were noted on echocardiograms. Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.  Company Comment: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.   Author conclusion: the clinical course suggests eosinophilic hypersensitivity myocarditis as described in the context of other drug-associated and vaccine-associated myocarditis.   This case was linked to MOD-2021-284001, MOD-2021-284002, MOD-2021-284003, MOD-2021-284004, MOD-2021-284005, MOD-2021-284006, MOD-2021-284007, MOD-2021-284008, MOD-2021-284009, MOD-2021-284010, MOD-2021-284011, MOD-2021-284012, MOD-2021-284013, MOD-2021-284014, MOD-2021-245527 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Upon internal review on 08-Sep-2021 E2B Company Number was updated from US-MODERNATX, INC.-MOD-2021-245527 to US-MODERNATX, INC.- MOD-2021-284015 On 05-Jul-2021: Follow up received by safety 07-Jul-2021 included a report type updated to literature-study based on the initial additional document received. On 07-Jul-2021: Follow up received by safety 08-Jul-2021 included a full text article added with no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.
A 30-year-old female patient, oriented in time and space, refers to the EMT feeling pain in the sternum 8 according to the numerical scale, 22 minutes after being administered her second dose of Pfizer. EMT proceeds to take his vital signs which were: 140/90 mmHg, Pulse 93 beats/min., Temp. 35.7 Celsius and Dext. 88 mg/dL. The case is consulted with Doctor. His recommendation was that the patient be transported to the Emergency Room. Patient was transported to the Hospital.
Dizzy; a little weak; This is a spontaneous report from a contactable consumer (patient). A 20-year-old female consumer received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Lot Number EH9899/Expiration date: not provided), via an unspecified route of administration, on 27Dec2020 at 8:07am (at the age of 20-years-old), as a single dose for COVID-19 vaccination. Relevant medical history was not provided. Concomitant medication included medroxyprogesterone acetate (DEPO-PROVERA) shot every 3 months for birth control. On 27Dec2020 at 9:41am, the patient reported that while she was at the grocery store, after she received the vaccine, she got kind of dizzy and a little weak. The consumer believed the effects were due to the vaccine, as she had not experienced this before. The outcome of the events dizzy and weak were unknown.
Extreme exhaustion, tiredness, fever, chills, nausea, weakness, headache, muscle pain,  joint pain, loss of appetite. This started about 5 hours after vaccination and continued for next day and a half. Patient took 2 Advil 200mg every 6 hours for one day and then 2 Excedrin 300 mg next day. Patient has discontinued Advil and Excedrin due to upset stomach. This evening, Friday, January 29 patient, stated he is feeling about 25% back to normal.  His appetite is improving.
Patient turned pale, clammy and sweaty, Eyes rolled back in head and started drawing hands up to chest, Seizure like activity. Pupils were dilated.
The patient was less than 12 years old; he had a lymphoma inflammation; he started complaining that his armpit  hurts more than where he took his shot,; he started to feel too much pain on his arm; he also had headache; This is a spontaneous report received from a contactable consumer (parent). A 9 years old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 07Jun2021 13:30 (Batch/Lot Number: twc/71), vaccinated at the age of 9 years old, as single dose for covid-19 immunisation. Patient received the first dose on 17May2021 16:00 in Arm Left. Medical history included attention deficit hyperactivity disorder.  The patient's concomitant medications were not reported.  Relevant past drug history included "Mold, ash three". Patient took his second dose on Monday at 1:30PM on his left arm, at 5 pm he went to his regular ninja class (the doctor said he could exercises normally) He did one exercise then he started to feel too much pain on his arm then he stopped. Next day, on 08Jun2021 he started complaining that his armpit hurts more than where he took his shot, he also had headache. Reporter took him to the doctor and he told me he had a lymphoma inflammation. Reporter not sure if it was from the exercise or for the vaccine, Reporter just want to report to help on the research. He is under antibiotics now and still with a lot of pain when you touch it. The doctor said if not get better in 1 week he is going to take an ultrasound. Outcome of reported events was recovering.
Pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Pain). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 14-MAR-2023 This case was reported by a patient via interactive digital media. The reporter asked who we could sue for the pain and who was the pharma company that supplied the shingles vaccination. The follow up would not possible as no contact details were available.
Pinkish injection site; Itching at injection site; Soreness at injection site; Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site). At the time of the report, VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: TCR was received. The outcome of events were updated to recovered. It contains significant information.
patient got the vaccine on 03/21/23 and called today 03/26/23 that she feels sore, and the left arm is red and itching. she went to urgent care and was given Keflex
Started with the area of vaccine administration becoming hot and swollen. Then developed a fever and after 2 days, she presented to the Hospital and was admitted 10/25-10/20/2014 for cellulitis treatment.
Immediately after receiving the vaccine at 1156, patient felt swelling in throat. The symptoms resolved a few minutes after, however they returned. She was given 25mg of Benadryl around 1201.  About 1230, patient took another 25mg of Benadryl. She said the swelling was better, but she was not at baseline. We continued to observe her until 1320. At that time, she felt that throat was normal. She was drinking water, walked to the restroom, and stated she felt better. We had her contact her sister who lives 2 doors down.